Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Double Cord Versus Haploidentical (BMT CTN 1101)

NCT01597778

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt Lymphoma, +30 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Cancer Center Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
View all 39 locations
View Trial Details
Completed

ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas

NCT01777152

Conditions
Anaplastic Large-Cell Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Shands Cancer Center / University of Florida Gainesville, Florida, United States
View all 144 locations
View Trial Details
Completed

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

NCT01321541

Conditions
DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Disease Attributes, +17 more
Locations
  • Arizona Clinical Research Center Tucson, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Highlands Oncology Group Bentonville, Arkansas, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
View all 131 locations
View Trial Details
Completed

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

NCT00000658

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • USC CRS Los Angeles, California, United States
  • UCLA CARE Center CRS Los Angeles, California, United States
  • Ucsf Aids Crs San Francisco, California, United States
  • University of Colorado Hospital CRS Aurora, Colorado, United States
View all 22 locations
View Trial Details
Completed

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

NCT00000703

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +21 more
Locations
  • Los Angeles County - USC Med Ctr Los Angeles, California, United States
  • UCLA CARE Ctr Los Angeles, California, United States
  • San Francisco AIDS Clinic / San Francisco Gen Hosp San Francisco, California, United States
  • George Washington Univ Med Ctr Washington D.C., District of Columbia, United States
View all 14 locations
View Trial Details
Completed

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

NCT00329030

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
  • University of Miami Miami, Florida, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
View all 36 locations
View Trial Details
Completed

Study of Nivolumab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) That Have Either Failed or Are Not Eligible for Autologous Stem Cell Transplant (CheckMate 139)

NCT02038933

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States
  • Winship Cancer Center Atlanta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 46 locations
View Trial Details
Completed

Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma

NCT01381692

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details

Related conditions